Nanjing Well Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Nanjing Well Pharmaceutical Co Ltd cash flow-to-debt ratio. Nanjing Well Pharmaceutical Co Ltd (603351) has a Cash Flow-to-Debt Ratio of 0.08x as of September 2025, meaning its operating cash flow of CN¥69.51 Million could theoretically repay 0% of its total liabilities (CN¥819.31 Million) in one year. Check earnings quality score of Nanjing Well Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Nanjing Well Pharmaceutical Co Ltd (2014–2025)
Cash flow-to-debt ratio of Nanjing Well Pharmaceutical Co Ltd from 2014 to 2025. Historical debt coverage capacity for Nanjing Well Pharmaceutical Co Ltd across 12 annual periods. Check how aggressively does Nanjing Well Pharmaceutical Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Nanjing Well Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2014–2025)
Nanjing Well Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2014 to 2025. Year-by-year debt coverage analysis for Nanjing Well Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 603351 cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.30x | CN¥238.24 Million | CN¥791.01 Million | ▼ -8.6% |
| 2024 | 0.33x | CN¥221.79 Million | CN¥672.72 Million | ▲ +88.2% |
| 2023 | 0.18x | CN¥120.24 Million | CN¥686.22 Million | ▲ +5.4% |
| 2022 | 0.17x | CN¥108.99 Million | CN¥655.76 Million | ▲ +757.0% |
| 2021 | -0.03x | CN¥-11.54 Million | CN¥456.01 Million | ▼ -109.1% |
| 2020 | 0.28x | CN¥93.30 Million | CN¥336.75 Million | ▼ -53.6% |
| 2019 | 0.60x | CN¥129.69 Million | CN¥217.06 Million | ▲ +81.4% |
| 2018 | 0.33x | CN¥63.76 Million | CN¥193.59 Million | ▼ -10.9% |
| 2017 | 0.37x | CN¥71.27 Million | CN¥192.73 Million | ▼ -54.9% |
| 2016 | 0.82x | CN¥128.18 Million | CN¥156.25 Million | ▲ +95.2% |
| 2015 | 0.42x | CN¥81.14 Million | CN¥193.01 Million | ▲ +0.8% |
| 2014 | 0.42x | CN¥74.62 Million | CN¥178.94 Million | — |